|
Model outcome
|
Level
|
Mortality
|
Mortality with lost to follow-up as a competing risk
|
|---|
|
Predictor
|
Adjusted hazard ratio (95 % CI)
|
p value
|
Adjusted hazard ratio (95 % CI)
|
p value
|
|---|
|
Treatment interruption
| |
0.21 (0.18, 0.23)
|
<0.01
|
0.95 (0.89, 1.02)
|
0.18
|
|
WHO stage at ART initiation
|
1
|
Ref.
| |
Ref.
| |
|
2
|
1.06 (0.81, 1.40)
|
0.67
|
1.06 (0.80, 1.40)
|
0.68
|
|
3
|
2.41 (1.95, 2.98)
|
<0.01
|
2.50 (2.02, 3.09)
|
<0.01
|
|
4
|
4.31 (3.48, 5.33)
|
<0.01
|
4.50 (3.64, 5.56)
|
<0.01
|
|
CD4 count at ART initiation (cells/μL)
|
<200
|
Ref.
| |
Ref.
| |
|
200–350
|
0.55 (0.48, 0.64)
|
<0.01
|
0.54 (0.47, 0.62)
|
<0.01
|
|
>350
|
0.41 (0.30, 0.55)
|
<0.01
|
0.40 (0.29, 0.53)
|
<0.01
|
